OA07282A - Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation. - Google Patents

Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.

Info

Publication number
OA07282A
OA07282A OA57876A OA57876A OA07282A OA 07282 A OA07282 A OA 07282A OA 57876 A OA57876 A OA 57876A OA 57876 A OA57876 A OA 57876A OA 07282 A OA07282 A OA 07282A
Authority
OA
OAPI
Prior art keywords
stabilization
preparation
pharmaceutical composition
composition containing
lyophilized pharmaceutical
Prior art date
Application number
OA57876A
Other languages
English (en)
Inventor
Kwan Henry King Hong
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26989028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA07282(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from ZA828580A external-priority patent/ZA828580B/xx
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA07282A publication Critical patent/OA07282A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
OA57876A 1981-12-23 1982-12-21 Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation. OA07282A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33405281A 1981-12-23 1981-12-23
ZA828580A ZA828580B (en) 1981-12-23 1982-11-19 Interferon formulations

Publications (1)

Publication Number Publication Date
OA07282A true OA07282A (fr) 1984-11-30

Family

ID=26989028

Family Applications (1)

Application Number Title Priority Date Filing Date
OA57876A OA07282A (fr) 1981-12-23 1982-12-21 Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.

Country Status (18)

Country Link
US (1) US4496537A (fr)
EP (1) EP0082481B2 (fr)
AU (1) AU558966B2 (fr)
CA (1) CA1207665A (fr)
DE (1) DE3262575D1 (fr)
DK (1) DK158873C (fr)
FI (1) FI70794C (fr)
HK (1) HK94487A (fr)
HU (1) HU190649B (fr)
IE (1) IE54468B1 (fr)
IL (1) IL67517A (fr)
MY (1) MY8700705A (fr)
NO (1) NO161036C (fr)
NZ (1) NZ202856A (fr)
OA (1) OA07282A (fr)
PH (1) PH19869A (fr)
PT (1) PT76013B (fr)
SG (1) SG70687G (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600583A (en) * 1982-09-07 1986-07-15 Tetra Consultants Inc. Pharmaceutical compositions
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
JPS6034919A (ja) * 1983-08-04 1985-02-22 Green Cross Corp:The ガンマ・インタ−フェロン組成物
JPH0651641B2 (ja) * 1983-08-29 1994-07-06 株式会社ミドリ十字 ガンマ・インターフェロン組成物
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
JPS60243028A (ja) * 1984-04-28 1985-12-03 Kyowa Hakko Kogyo Co Ltd インタ−フエロンの可溶化方法
EP0168008A3 (fr) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Composition stable d'interféron-gamma
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4847079A (en) * 1985-07-29 1989-07-11 Schering Corporation Biologically stable interferon compositions comprising thimerosal
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
CA1320905C (fr) * 1986-11-06 1993-08-03 Joseph M. Cummins Traitement d'affections immuno-resistantes
US4851220A (en) * 1986-11-26 1989-07-25 Schering Corporation Stable oleaginous gel
US4853218A (en) * 1987-02-24 1989-08-01 Schering Corporation Zinc-protamine-alpha interferon complex
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US4871538A (en) * 1987-07-13 1989-10-03 Schering Corporation Insoluble copper-alpha interferon complex
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
ATE90570T1 (de) * 1988-01-29 1993-07-15 Sumitomo Pharma Verbesserte formulierungen mit kontrollierter abgabe.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
IT1240314B (it) * 1989-09-28 1993-12-07 Immunobiology Research Institutes, Inc. Formulazioni acquose stabilizzate di piccoli peptidi.
EP0607275A4 (fr) * 1991-10-11 1995-02-22 Mark Cedric Gillies Traitement des fibroses ophtalmiques par l'interferon alpha.
AU669132B2 (en) * 1991-10-11 1996-05-30 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
US5358708A (en) * 1993-01-29 1994-10-25 Schering Corporation Stabilization of protein formulations
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
EP0820299B1 (fr) * 1995-02-06 2002-04-24 Genetics Institute, Inc. Formulations de preparation d'interleukine-12
US5656730A (en) * 1995-04-07 1997-08-12 Enzon, Inc. Stabilized monomeric protein compositions
US6540993B1 (en) 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
CN1222315C (zh) * 1996-12-24 2005-10-12 拜奥根有限公司 稳定的液体干扰素制剂
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
PT1224940E (pt) † 1997-09-23 2005-01-31 Rentschler Biotech Gmbh Formulacoes liquidas de intrferao beta
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
DE69835165T2 (de) * 1997-10-14 2007-06-06 Eisai Co., Ltd. Pharmazeutische Formulierung, die Glycin als Stabilisator umfasst
US20090074718A1 (en) * 1997-10-16 2009-03-19 Ivarie Robert D Avian derived erythropoietin
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
US8563803B2 (en) * 1997-10-16 2013-10-22 Synageva Biopharma Corp. Method of making protein in an egg of a transgenic chicken
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
US7511120B2 (en) * 1997-10-16 2009-03-31 Synageva Biopharma Corp. Glycosylated G-CSF obtained from a transgenic chicken
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
PT1129111E (pt) 1998-11-12 2008-12-22 Schering Corp Métodos para a conversão de isoformas de interferão e seus produtos
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
KR100771294B1 (ko) * 1999-12-14 2007-10-29 써모 바이오스타, 인크. 폴리펩티드 및 항원 안정화 희석제
US7666995B2 (en) 2000-11-03 2010-02-23 Pestka Biomedical Laboratories Interferons, uses and compositions related thereto
WO2002053136A1 (fr) * 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Preparations a liberation soutenue
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
CN101700401B (zh) 2002-01-18 2013-08-14 比奥根艾迪克Ma公司 具有用于共轭生物活性化合物的部分的聚亚烷基二醇
US20050232899A1 (en) * 2002-05-31 2005-10-20 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US6830744B2 (en) 2002-05-31 2004-12-14 Aradigm Corporation Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
US7803362B2 (en) * 2003-01-24 2010-09-28 Synageva Biopharma Corp. Glycosylated interferon alpha
JP4699991B2 (ja) * 2003-04-02 2011-06-15 アレス トレーディング ソシエテ アノニム 非イオン性界面活性剤を一緒に伴うｆｓｈ及びｌｈの液体医薬組成物
CA2526099C (fr) * 2003-06-20 2013-02-05 Ares Trading Sa Formulations lyophilisees a base de fsh/lh
KR20070045244A (ko) * 2004-08-12 2007-05-02 쉐링 코포레이션 안정한 페길화된 인터페론 제형
KR100617648B1 (ko) * 2005-02-25 2006-09-05 김응권 혈장 또는 혈청을 함유하는 아벨리노 각막 이영양증 치료용약학 조성물
US20070003564A1 (en) * 2005-06-30 2007-01-04 Hurley John K Diluent for immunohistochemistry
US7931919B2 (en) * 2005-08-12 2011-04-26 The United States Of America As Represented By The Secretary Of The Army Method of producing glycine-stabilized, lyophilized plasma
CU23432B6 (es) 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
US7812127B2 (en) 2006-03-17 2010-10-12 Synageva Biopharma Corp. Glycosylated human G-CSF
US20090105462A1 (en) * 2006-11-09 2009-04-23 Ivarie Robert D Glycosylated erythropoietin
BRPI0717674A2 (pt) * 2006-11-24 2014-04-08 Cadila Healthcare Ltd ' formulação compreendendo conjugados de peg-interferon alfa, processo de liofilização da formulação e formulação liofilizada '
EP2126071A4 (fr) 2007-01-26 2010-12-08 Synageva Biopharma Corp Expression transgenique chez des oiseaux
AU2008269086B2 (en) 2007-06-25 2014-06-12 Amgen Inc. Compositions of specific binding agents to hepatocyte growth factor
US20100297081A1 (en) * 2007-12-18 2010-11-25 Huang Yanshan Pharmaceutical formulation containing recombinant human serum albumin-interferon alpha fusion protein
WO2010033854A2 (fr) 2008-09-19 2010-03-25 Synageva Biopharma Corp. Protéines de fusion dérivées d’une cellule aviaire
HUE039240T2 (hu) 2009-11-03 2018-12-28 Grifols Therapeutics Llc Kompozíció, eljárás és készlet alfa-1 proteináz inhibitorhoz
US8648177B2 (en) 2009-11-24 2014-02-11 Grifols Therapeutics Inc. Lyophilization methods, compositions, and kits
US20130008191A1 (en) * 2011-07-07 2013-01-10 Suchak Naresh J Methods for freezing and thawing proteins
DK3183264T3 (da) 2014-08-19 2020-11-02 Biogen Ma Inc Pegyleringsfremgangsmåde
CN106421755A (zh) * 2016-11-03 2017-02-22 广州凯耀资产管理有限公司 一种干扰素组合物及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553497A (en) * 1946-02-04 1951-05-15 L Inst De Serotherapie Hemopoi Hemostatic composition of thrombin and glycocoll
US2806815A (en) * 1955-04-12 1957-09-17 Ortho Pharma Corp Stabilized hyaluronidase
GB866423A (en) * 1958-03-21 1961-04-26 Armour & Co Improvements in or relating to chymotrypsin solutions
US3016398A (en) * 1959-04-06 1962-01-09 Staley Mfg Co A E Stabilized phytic acid solutions and methods of preparation thereof
GB900115A (en) * 1960-06-15 1962-07-04 Armour & Co Improvements in or relating to trypsin solutions
JPS5495795A (en) * 1978-01-13 1979-07-28 Toray Ind Inc Production of interferon
IN150740B (fr) * 1978-11-24 1982-12-04 Hoffmann La Roche
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
US4198479A (en) * 1979-03-30 1980-04-15 Merck & Co., Inc. Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
US4337242A (en) * 1980-02-05 1982-06-29 Merck & Co., Inc. Vaccine stabilizer containing L-glutamic acid and L-arginine
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation

Also Published As

Publication number Publication date
NO161036C (no) 1989-06-28
IE823046L (en) 1983-06-23
EP0082481B1 (fr) 1985-03-13
EP0082481A1 (fr) 1983-06-29
MY8700705A (en) 1987-12-31
SG70687G (en) 1988-02-19
NO824285L (no) 1983-06-24
DK158873C (da) 1990-12-31
HU190649B (en) 1986-09-29
DK158873B (da) 1990-07-30
NO161036B (no) 1989-03-20
IE54468B1 (en) 1989-10-25
CA1207665A (fr) 1986-07-15
FI70794C (fi) 1986-10-27
PT76013A (en) 1983-01-01
AU558966B2 (en) 1987-02-19
IL67517A0 (en) 1983-05-15
AU9168882A (en) 1983-06-30
DE3262575D1 (en) 1985-04-18
FI70794B (fi) 1986-07-18
US4496537A (en) 1985-01-29
FI824366A0 (fi) 1982-12-20
DK158771B (da) 1990-07-16
EP0082481B2 (fr) 1990-09-12
HK94487A (en) 1987-12-18
DK565882A (da) 1983-06-24
PH19869A (en) 1986-08-13
IL67517A (en) 1988-11-30
PT76013B (en) 1986-03-11
NZ202856A (en) 1985-12-13
FI824366L (fi) 1983-06-24

Similar Documents

Publication Publication Date Title
OA07282A (fr) Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation.
OA07103A (fr) Nouvelles 1,2-diaminocyclobutène-3,4-diones, leur procédé de préparation et composition pharmaceutique les contenant.
OA08647A (fr) Dérivés d'imidazole, procédés pour leur préparation et composition pharmaceutique les contenant.
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2531087B1 (fr) Nouvelle forme d'ester de cefuroxime, procede pour sa preparation et composition pharmaceutique la contenant
PT84964A (en) Process for the preparation of 1,5-diaryl-3-substituted-pyrazoles and of pharmaceutical compositions containing them
FR2569402B1 (fr) Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant
PT87492A (pt) Process for the preparation of benzo ]b" pyrrans and pyranopyridines and pharmaceutical compositions containing them
FR2567131B1 (fr) Nouveaux derives de ganglioside, procede pour leur obtention et composition pharmaceutique les contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
IL67172A (en) Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,process for their preparation and pharmaceutical agents containing these compounds
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
OA09441A (fr) "Procédés de préparation de ptéridin-4(3H)-ones, et de compositions médicamenteuses les contenant".
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
OA07341A (fr) Nouveaux oximéthers, procédé pour leur préparation, agents contenant les nouveaux oximéthers et leur application.
PT75042A (en) Process for the preparation of apovincaminates and pharmaceutical compositions containing them
FR2600061B1 (fr) Derives d'indole, composition pharmaceutique les contenant et procede pour leur preparation
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
PT76870A (en) Process for the preparation of 1,4-dihydropiridine derivatives and pharmaceutical compositions containing them
FR2519021B1 (fr) Procede de stabilisation de la serrapeptase, composition contenant cette serrapeptase stabilisee et preparation de cette composition
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
PT75265A (en) Process for the preparation of diazabicyclicononanes substituted and pharmaceutical composition containing them
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
HU901579D0 (en) Process for the preparation of substituted /quinolin-2-yl-methoxy/-phenyl-n'n-sulfonyl-ureas and pharmaceutical compositions containing such compounds